bone.jpgIPNews® – The Federal Circuit on Thursday shot down Hoffmann-La Roche Inc.’s appeal of a district court’s refusal to grant it a patent injunction stopping three generic drug makers from producing their own versions of Roche’s osteoporosis drug Boniva.

Roche could not prove it was likely to overcome Apotex Inc., Watson Pharmaceuticals Inc. and Mylan